Inactive Instrument

Other languages Transgenomic Inc Nasdaq

Equities

US89365K3059

End-of-day quote Nasdaq Other stock markets
- ^USD	-

May. 14	Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Precipio, Inc. announced that it expects to receive $0.5 million in funding	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer	Feb. 06
Sector Update: Health Care Stocks Slipping Late Afternoon	Jan. 17
Sector Update: Health Care Stocks Edge Down Wednesday Afternoon	Jan. 17
Precipio Signs Distribution Deal in Japan, Gets First Order; Shares Rise	Jan. 17
Precipio, Inc. Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	Jan. 17
Precipio, Inc. Announces Board Changes	Jan. 02
Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Precipio Says Lower Product Revenue Needed to Achieve Cash Flow Breakeven	23-09-25
Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
End in sight for U.S. insider trading case over healthcare leaks	23-08-01
Precipio's Omnia?? Methodology Enables Diagnosis of MDS with Peripheral Blood Instead of Bone Marrow Biopsy	23-06-14
Precipio, Inc. Enters into Collaboration with Prestigious New York-Based Institution to Develop Revolutionary Brain Tumor Panel Using Hemescreen Technology	23-06-13
Precipio Prices $2 Million Registered Direct Offering, Concurrent Private Placement	23-06-08
Precipio, Inc.'s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology	23-05-22
Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Precipio Signs Another HemeScreen™? Customer	23-05-04
Precipio Files $50 Million Mixed Shelf	23-04-17
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Transgenomic Inc Nasdaq

Equities

US89365K3059

Other languages

Filters